Associations of ALT/AST, a marker of hepatosteatosis, with pulse rate in young women and with blood pressure in middle-aged women independently of abdominal fat accumulation and insulin resistance
© The Japan Diabetes Society 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law..
We examined whether alanine aminotransferase/aspartate aminotransferase (ALT/AST), a marker of hepatosteatosis, may be associated with a wider constellation of variables related to metabolic syndrome in Japanese women. Body fat and distribution, and metabolic syndrome-related variables were measured in 311 young and 148 middle-aged women. We had Pearson's correlation analysis and then stepwise multivariate linear regression analyses. In both middle-aged and young women, ALT/AST was associated with homeostasis model assessment insulin resistance (HOMA-IR), trunk/leg fat ratio and pulse rate. In middle-aged women but not in young women, ALT/AST was associated with waist circumference, fasting glucose, triglyceride, HDL cholesterol (inversely), systolic, diastolic and mean blood pressure (BP). Further, in middle-aged women only, the ratio was associated with BMI, percentage body fat, apolipoprotein B and plasminogen activator inhibitor-1. Among these variables, pulse rate in young women and systolic BP in middle-aged women were associated with ALT/AST independently of trunk/leg fat ratio, a sophisticated measures of abdominal fat accumulation, HOMA-IR, fasting glucose, triglyceride and HDL cholesterol. In conclusion, ALT/AST was associated with pulse rate in young women and with systolic BP in middle-aged women independently of abdominal fat accumulation and insulin resistance. It is noted that their waist circumference averaged < 80 cm and ALT < 30 U/L, suggesting minimum accumulation of abdominal and hepatic fat, respectively, key drivers of insulin resistance and metabolic syndrome.
Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-023-00689-z.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Diabetology international - 15(2024), 2 vom: 30. März, Seite 270-277 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Minato-Inokawa, Satomi [VerfasserIn] |
---|
Links: |
---|
Themen: |
ALT/AST |
---|
Anmerkungen: |
Date Revised 26.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1007/s13340-023-00689-z |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370145046 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370145046 | ||
003 | DE-627 | ||
005 | 20240327000237.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240326s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s13340-023-00689-z |2 doi | |
028 | 5 | 2 | |a pubmed24n1349.xml |
035 | |a (DE-627)NLM370145046 | ||
035 | |a (NLM)38524930 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Minato-Inokawa, Satomi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Associations of ALT/AST, a marker of hepatosteatosis, with pulse rate in young women and with blood pressure in middle-aged women independently of abdominal fat accumulation and insulin resistance |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 26.03.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © The Japan Diabetes Society 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
520 | |a We examined whether alanine aminotransferase/aspartate aminotransferase (ALT/AST), a marker of hepatosteatosis, may be associated with a wider constellation of variables related to metabolic syndrome in Japanese women. Body fat and distribution, and metabolic syndrome-related variables were measured in 311 young and 148 middle-aged women. We had Pearson's correlation analysis and then stepwise multivariate linear regression analyses. In both middle-aged and young women, ALT/AST was associated with homeostasis model assessment insulin resistance (HOMA-IR), trunk/leg fat ratio and pulse rate. In middle-aged women but not in young women, ALT/AST was associated with waist circumference, fasting glucose, triglyceride, HDL cholesterol (inversely), systolic, diastolic and mean blood pressure (BP). Further, in middle-aged women only, the ratio was associated with BMI, percentage body fat, apolipoprotein B and plasminogen activator inhibitor-1. Among these variables, pulse rate in young women and systolic BP in middle-aged women were associated with ALT/AST independently of trunk/leg fat ratio, a sophisticated measures of abdominal fat accumulation, HOMA-IR, fasting glucose, triglyceride and HDL cholesterol. In conclusion, ALT/AST was associated with pulse rate in young women and with systolic BP in middle-aged women independently of abdominal fat accumulation and insulin resistance. It is noted that their waist circumference averaged < 80 cm and ALT < 30 U/L, suggesting minimum accumulation of abdominal and hepatic fat, respectively, key drivers of insulin resistance and metabolic syndrome | ||
520 | |a Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-023-00689-z | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a ALT/AST | |
650 | 4 | |a Blood pressure | |
650 | 4 | |a Hepatosteatosis | |
650 | 4 | |a Metabolic syndrome | |
650 | 4 | |a Pulse rate | |
650 | 4 | |a Triglyceride | |
700 | 1 | |a Tsuboi-Kaji, Ayaka |e verfasserin |4 aut | |
700 | 1 | |a Honda, Mari |e verfasserin |4 aut | |
700 | 1 | |a Takeuchi, Mika |e verfasserin |4 aut | |
700 | 1 | |a Kitaoka, Kaori |e verfasserin |4 aut | |
700 | 1 | |a Kurata, Miki |e verfasserin |4 aut | |
700 | 1 | |a Wu, Bin |e verfasserin |4 aut | |
700 | 1 | |a Kazumi, Tsutomu |e verfasserin |4 aut | |
700 | 1 | |a Fukuo, Keisuke |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetology international |d 2014 |g 15(2024), 2 vom: 30. März, Seite 270-277 |w (DE-627)NLM26457950X |x 2190-1678 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2024 |g number:2 |g day:30 |g month:03 |g pages:270-277 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s13340-023-00689-z |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2024 |e 2 |b 30 |c 03 |h 270-277 |